Leukaemia Drug

EDM number 1483 in 2002-03, proposed by Ian Gibson on 26/06/2003.

That this House welcomes the National Institute for Clinical Excellence's provisional recommendation that Glivec should be available on the NHS as a first-line treatment of people with chronic myeloid leukaemia in the chronic phase; and calls on NICE to issue final guidance as soon as possible.

This motion has been signed by a total of 47 MPs.